David Provenzale Titinger

David Provenzale Titinger

Auto-generated profile, based on publicly available information

David Provenzale Titinger

Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, BR

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
DTDavid Provenzale Titinger
David Provenzale Titinger
LLLuiz Augusto Ferreira Lisboa
Luiz Augusto Ferreira Lisboa
BMBruna La Regina Matrangolo
Bruna La Regina Matrangolo
LDLuis Alberto Oliveira Dallan
Luis Alberto Oliveira Dallan
ETEvelinda Marramon Trindade
Evelinda Marramon Trindade
FJFirst100 Jatene
First100 Jatene
Heart surgery has developed with increasing patient complexity. To assess the use of resources and real costs stratified by risk factors of patients submitted to surgical cardiac procedures and to compare them with the values reimbursed by the Brazilian Unified Health System (SUS). All cardiac surgery procedures performed between January and July 2013 in a tertiary referral center were analyzed. Demographic and clinical data allowed the calculation of the value reimbursed by the Brazilian SUS. Patients were stratified as low, intermediate and high-risk categories according to the EuroSCORE. Clinical outcomes, use of resources and costs (real costs versus SUS) were compared between established risk groups. Postoperative mortality rates of low, intermediate and high-risk EuroSCORE risk strata showed a significant linear positive correlation (EuroSCORE: 3.8%, 10%, and 25%; p < 0.0001), as well as occurrence of any postoperative complication EuroSCORE: 13.7%, 20.7%, and 30.8%, respectively; p = 0.006). Accordingly, length-of-stay increased from 20.9 days to 24.8 and 29.2 days (p < 0.001). The real cost was parallel to increased resource use according to EuroSCORE risk strata (R$ 27.116,00 ± R$ 13.928,00 versus R$ 34.854,00 ± R$ 27.814,00 versus R$ 43.234,00 ± R$ 26.009,00, respectively; p < 0.001). SUS reimbursement also increased (R$ 14.306,00 ± R$ 4.571,00 versus R$ 16.217,00 ± R$ 7.298,00 versus R$ 19.548,00 ± R$935,00; p < 0.001). However, as the EuroSCORE increased, there was significant difference (p < 0.0001) between the real cost increasing slope and the SUS reimbursement elevation per EuroSCORE risk strata. Higher EuroSCORE was related to higher postoperative mortality, complications, length of stay, and costs. Although SUS reimbursement increased according to risk, it was not proportional to real costs.

7 October 2026 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
FTFlavio Tarasoutchi
Flavio Tarasoutchi
JFJoao Ricardo Fernandes
Joao Ricardo Fernandes
VRVitor Emer Egypto Rosa
Vitor Emer Egypto Rosa
RSRoney Orismar Sampaio
Roney Orismar Sampaio
DSDiana Patricia Lamprea Sepulveda
Diana Patricia Lamprea Sepulveda
WEWilliam Antonio de Magalhães Esteves
William Antonio de Magalhães Esteves
Sumário […] Diretriz Brasileira de Valvopatias – 2026 Sumário […] Diretriz Brasileira de Valvopatias – 2026

13 February 2023 in International Journal of Cardiovascular Sciences
Verified
Journal Article
Open access
PDF file
DTDavid Provenzale Titinger
David Provenzale Titinger
VRVitor Emer Egypto Rosa
Vitor Emer Egypto Rosa
MOMarcelo Eidi Ochiai
Marcelo Eidi Ochiai
TATarso Augusto Accorsi
Tarso Augusto Accorsi
JFJoao Ricardo Fernandes
Joao Ricardo Fernandes
FTFlavio Tarasoutchi
Flavio Tarasoutchi
Introduction Valvular heart disease contributes to an important portion of hospital admissions. It can progress to heart failure and death, and it ranks eighth among the causes of mortality due to cardiovascular diseases in Brazil. From the moment that a valve disease becomes anatomically important and has clinical repercussions, only interventional treatment (conventional surgery or transcatheter technique) is able to alter the natural course of the disease., The choice of intervention leads to the need for individualized evaluation of the [...] Introduction Valvular heart disease contributes to an important portion of hospital admissions. It can progress to heart failure and death, and it ranks eighth among the causes of mortality due to cardiovascular diseases in Brazil. From the moment that a valve disease becomes anatomically important and has clinical repercussions, only interventional treatment (conventional surgery or transcatheter technique) is able to alter the natural course of the disease., The choice of intervention leads to the need for individualized evaluation of the